Xiao Hong-guang, Huang Ze-hong, Liu Han-Xin, Lin Yong-ping
Department of Clinical Laboratory, Guangzhou Medical College, Guangzhou 510120, China.
Di Yi Jun Yi Da Xue Xue Bao. 2005 May;25(5):550-1.
To investigate the clinical implications of cardiac troponin I (cTnI), myoglobin (Mb), creatine kinase (CK) and creatine kinase isoenzyme (CK-MB) in patients with acute myocardial infarction (AMI).
The serum concentrations of cTnI and Mb were determined in 50 patients with AMI 2 to 4 h after chest pain onset and compared with those measured in 50 age-matched healthy subjects.
The serum levels of cTnI, CK-MB and CK in patients with AMI were significantly higher than those in the control group. Mb levels in AMI group were above the normal range. Mb, CK-MB, CK and cTnI reached the peak levels at 8+/-2.2, 18.1+/-3.2, 19.4+/-4.1 and 18.6+/-2.9 h after the onset, respectively, and their levels increased with the aggravation of AMI and were reduced to the normal levels with the amelioration of the disease. All the 4 indices were normal in the control group.
cTnI and Mb are reliable biochemical markers for early diagnosis of AMI and the changes in their serum levels have clinical significance in diagnoses and prognostic judgment of AMI.
探讨心肌肌钙蛋白I(cTnI)、肌红蛋白(Mb)、肌酸激酶(CK)及肌酸激酶同工酶(CK-MB)在急性心肌梗死(AMI)患者中的临床意义。
测定50例胸痛发作后2至4小时的AMI患者血清中cTnI和Mb的浓度,并与50例年龄匹配的健康受试者的测定结果进行比较。
AMI患者血清中cTnI、CK-MB和CK水平显著高于对照组。AMI组Mb水平高于正常范围。Mb、CK-MB、CK和cTnI分别在发病后8±2.2、18.1±3.2、19.4±4.1和18.6±2.9小时达到峰值水平,且其水平随AMI病情加重而升高,随病情好转而降至正常水平。对照组所有4项指标均正常。
cTnI和Mb是早期诊断AMI的可靠生化标志物,其血清水平变化对AMI的诊断和预后判断具有临床意义。